Journal of the Practice of Cardiovascular Sciences

RESEARCH CORRESPONDENCE
Year
: 2017  |  Volume : 3  |  Issue : 1  |  Page : 63--66

HeartWare HVAD: Postoperative issues in our first patient


Sarvesh Pal Singh1, Sandeep Seth2, Manoj Kumar Sahu1, Balram Airan1 
1 Department of Cardiothoracic and Vascular Surgery, Cardio-Thoracic Sciences Center, All India Institute of Medical Sciences, New Delhi, India
2 Department of Cardiology, Cardio-Thoracic Sciences Center, All India Institute of Medical Sciences, New Delhi, India

Correspondence Address:
Sarvesh Pal Singh
Department of Cardiothoracic and Vascular Surgery, C N Center, All India Institute of Medical Sciences, New Delhi - 110 029
India

Ventricular assist devices (VADs) serve as a bridge to heart transplant or destination therapy in end stage heart failure. HeartWare HVAD is a second generation, non pulsatile, magnetically levitated centrifugal pump, which is preload dependent and afterload sensitive. It has an inlet that is cored into the left ventricular wall and an outflow that is attached to a graft which is sutured into the ascending aorta. The Registry to Evaluate the HeartWare Left Ventricular Assist System (ReVOLVE) registry has reported a 2 year survival of 76% and 5 year survival of 59%. We present our experience of the first HeartWare 2 HVAD implanted at our institute.


How to cite this article:
Singh SP, Seth S, Sahu MK, Airan B. HeartWare HVAD: Postoperative issues in our first patient.J Pract Cardiovasc Sci 2017;3:63-66


How to cite this URL:
Singh SP, Seth S, Sahu MK, Airan B. HeartWare HVAD: Postoperative issues in our first patient. J Pract Cardiovasc Sci [serial online] 2017 [cited 2023 Feb 2 ];3:63-66
Available from: https://www.j-pcs.org/article.asp?issn=2395-5414;year=2017;volume=3;issue=1;spage=63;epage=66;aulast=Singh;type=0